Francesca Telese on LinkedIn: Our latest work on the role of cannabinoids in inflammation: The…
The cannabinoid agonist WIN 55,212-2 (WIN) reversibly inhibits... | Download Scientific Diagram
The cannabinoid receptor agonist WIN 55,212-2 (WIN) (( R)... | Download Scientific Diagram
Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission | Scientific Reports
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Effect of the synthetic cannabinoid agonist WIN 55212-2 (WIN) on... | Download Scientific Diagram
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes | eNeuro
The Synthetic Cannabinoid WIN 55,212-2 Elicits Death in Human Cancer Cell Lines | Anticancer Research
Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells - ScienceDirect
What is a cannabinoid? — Why Not THC
Cannabinoid Signaling Insights to Future Pharmacotherapeutic Development | News & Announcements | Cayman Chemical
WIN 55,212-2 mesylate Supplier | CAS 131543-23-2 | WIN552122 | Tocris Bioscience
Regional Differences in Cannabinoid Receptor/G-protein Coupling in Rat Brain | Journal of Pharmacology and Experimental Therapeutics
The effect of the cannabinoid receptor antagonist AM251 on WIN 55,... | Download Scientific Diagram
The effect of cannabinoid receptor agonist WIN 55,212–2 on anxiety‐like behavior and locomotion in a genetic model of absence seizures in the elevated plus‐maze - Cassar - 2022 - CNS Neuroscience &
Receptors | Free Full-Text | Pharmacology of Minor Cannabinoids at the Cannabinoid CB1 Receptor: Isomer- and Ligand-Dependent Antagonism by Tetrahydrocannabivarin
Gestational exposure to the cannabinoid WIN 55,212-2 and its effect on the innate intestinal immune response | Scientific Reports
WIN-55212-2 mesylate Supplier | CAS 131543-23-2 | Focus Biomolecules
WIN 55,212-2 mesylate | ≥99%(HPLC) | CB receptor agonist | AdooQ®
Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity - Mouro - 2018 - Journal of Neurochemistry - Wiley Online Library
Cannabinoid WIN‑55,212‑2 mesylate inhibits ADAMTS‑4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan‑1
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain | Molecular Psychiatry
Long lasting effects of chronic WIN55,212-2 treatment on mesostriatal dopaminergic and cannabinoid systems in the rat brain - ScienceDirect
Win 55212-2 | C27H26N2O3 | CID 5311501 - PubChem
